May 21-23 - MINUTES OF MEETING 
24 
participation unless requested by the RAC. Dr. Ahmed said that speaking 
time for RAC members may have to be limited. Dr. Baltimore said that 
debate between RAC members and non-members is inappropriate. He said 
that outsiders should be allowed to speak but not became part of the 
debate. Dr. Kutter noted that the RAC now has broader representation 
or. the Caranittee than previously which makes it less necessary to hear 
frcm non-RAC members. Ms. King said that the working group should consider 
a uniform policy in regard to submitters being present at the meeting. 
Dr. Krimsky noted that there are a number of different categories of 
people who may wish to speak at the meeting. Dr. Young suggested that 
a distinction might be drawn between generic issues and narrowly- focused 
individual proposals. 
XXI. HEALTH SURVEILLANCE 
The RAC discussed a document (673) entitled "Analysis of Health Surveillance 
Requirement for Recombinant DNA Workers" prepared by ORDA at the request 
of Dr. Campbell. Dr. Campbell had requested a clarification frcm the 
NIH that the requirement for consideration of health surveillance in the 
revised Guidelines is for protection of the health of workers, and not 
for the gathering of medical statistics. The RAC had asked for the 
opportunity to review such a document. Dr. Campbell suggested that ORDA 
retain the document and distribute it on request. It was agreed that 
there would be further discussion of this document at the next meeting. 
XXII. OCCUPATIONAL HEALTO IMPLICATIONS 
Dr. Setlow reported that Dr. Parkinson requested a discussion on occupational 
health implications with representatives of NIOSH and OSHA present. One 
member questioned the appropriateness of this as an agenda item as no 
substantial background information has been provided to RAC members. 
Dr. Setlow said that she will request documentation from Dr. Parkinson 
prior to the next meeting. 
XXIII. CONTAINMENT LEVELS FOR CLONING EUKARYOTIC VIRUSES IN SACCHAROMYCES 
CEREVTSIAE AND N EUROS PORA CRASSA HV SYSTEMS 
The RAC at its February 1979 meeting recommended the use of Saccharcmyces 
cerevisiae and Neurospora crassa as HV1 systems and specified certain 
strains and vectors of S. cerevisiae as HV2 host-vector systems. The 
certified systems were to be used as follows: 
"In accord with Section III-C-5, host-vector 
systems which have been approved as HV1 
[ 119 ] 
